These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24557047)

  • 1. Regulation of inflammation and T cells by glycogen synthase kinase-3: links to mood disorders.
    Beurel E
    Neuroimmunomodulation; 2014; 21(2-3):140-4. PubMed ID: 24557047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is glycogen synthase kinase-3 a central modulator in mood regulation?
    Li X; Jope RS
    Neuropsychopharmacology; 2010 Oct; 35(11):2143-54. PubMed ID: 20668436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia.
    Cole AR
    FEBS J; 2013 Nov; 280(21):5213-27. PubMed ID: 23796137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase 3: a point of convergence for the host inflammatory response.
    Wang H; Brown J; Martin M
    Cytokine; 2011 Feb; 53(2):130-40. PubMed ID: 21095632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics.
    Jope RS; Yuskaitis CJ; Beurel E
    Neurochem Res; 2007; 32(4-5):577-95. PubMed ID: 16944320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation.
    Hofmann C; Dunger N; Schölmerich J; Falk W; Obermeier F
    Inflamm Bowel Dis; 2010 Nov; 16(11):1850-8. PubMed ID: 20848477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).
    Beurel E; Michalek SM; Jope RS
    Trends Immunol; 2010 Jan; 31(1):24-31. PubMed ID: 19836308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.
    Polter A; Beurel E; Yang S; Garner R; Song L; Miller CA; Sweatt JD; McMahon L; Bartolucci AA; Li X; Jope RS
    Neuropsychopharmacology; 2010 Jul; 35(8):1761-74. PubMed ID: 20357757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior.
    Cheng Y; Pardo M; Armini RS; Martinez A; Mouhsine H; Zagury JF; Jope RS; Beurel E
    Brain Behav Immun; 2016 Mar; 53():207-222. PubMed ID: 26772151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases.
    Beurel E
    Front Mol Neurosci; 2011; 4():18. PubMed ID: 21941466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response.
    Wang H; Brown J; Gu Z; Garcia CA; Liang R; Alard P; Beurel E; Jope RS; Greenway T; Martin M
    J Immunol; 2011 May; 186(9):5217-26. PubMed ID: 21422248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.
    Coant N; Simon-Rudler M; Gustot T; Fasseu M; Gandoura S; Ragot K; Abdel-Razek W; Thabut D; Lettéron P; Ogier-Denis E; Ouziel R; Devière J; Lizard G; Tellier Z; Lebrec D; Moreau R
    J Hepatol; 2011 Oct; 55(4):784-93. PubMed ID: 21334395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting Glycogen Synthase Kinase 3 Reverses Obesity-Induced White Adipose Tissue Inflammation by Regulating Apoptosis Inhibitor of Macrophage/CD5L-Mediated Macrophage Migration.
    Wang L; Wang Y; Zhang C; Li J; Meng Y; Dou M; Noguchi CT; Di L
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2103-2116. PubMed ID: 30026270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.
    Jope RS
    Front Mol Neurosci; 2011; 4():16. PubMed ID: 21886606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.
    Jope RS; Roh MS
    Curr Drug Targets; 2006 Nov; 7(11):1421-34. PubMed ID: 17100582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression.
    McCallum RT; Perreault ML
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders.
    Gould TD; Picchini AM; Einat H; Manji HK
    Curr Drug Targets; 2006 Nov; 7(11):1399-409. PubMed ID: 17100580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stressed and Inflamed, Can GSK3 Be Blamed?
    Jope RS; Cheng Y; Lowell JA; Worthen RJ; Sitbon YH; Beurel E
    Trends Biochem Sci; 2017 Mar; 42(3):180-192. PubMed ID: 27876551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.
    Beurel E; Grieco SF; Jope RS
    Pharmacol Ther; 2015 Apr; 148():114-31. PubMed ID: 25435019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.